This announcement is a separate document:
中國抗體-B：自願公告SM17新藥研究申請獲國家藥監局批准
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SM17 BY NMPA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.